Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases
Denise Busscher, Reinier A. Boon, Rio P. Juni
Clinical Science (2022) Vol. 136, Iss. 15, pp. 1157-1178
Open Access | Times Cited: 43
Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases
Luis Alberto Bravo-Vázquez, Sujay Paul, Miriam Guadalupe Colín-Jurado, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 8
Reconceptualizing Endothelial-to-mesenchymal transition in atherosclerosis: Signaling pathways and prospective targeting strategies
Nanlin You, Guohao Liu, Mengchen Yu, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Expression level and diagnostic value of exosomal NEAT1/miR‐204/MMP‐9 in acute ST‐segment elevation myocardial infarction
Zhenzhen Chen, Youyou Yan, Junduo Wu, et al.
IUBMB Life (2020) Vol. 72, Iss. 11, pp. 2499-2507
Open Access | Times Cited: 56
Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis
Qingyan Huang, Yuhong Gan, Zhikang Yu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 41
Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis
Xiaoxin Li, Hongzhao Qi, Weigang Cui, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3118-3132
Open Access | Times Cited: 37
Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis
Bandana Singh, Kui Cui, Shahram Eisa-Beygi, et al.
Vascular Pharmacology (2024) Vol. 155, pp. 107368-107368
Open Access | Times Cited: 6
Vascular Endothelial Senescence: Pathobiological Insights, Emerging Long Noncoding RNA Targets, Challenges and Therapeutic Opportunities
Xinghui Sun, Mark W. Feinberg
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 40
Long non-coding RNA H19 in atherosclerosis: what role?
Xian Shi, Yating Wei, Heng Li, et al.
Molecular Medicine (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 39
The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets
Huilei Zhao, Ziqi Tan, Jin Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115067-115067
Open Access | Times Cited: 13
The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease
Yuan Yao, Gang Xiong, Xuejun Jiang, et al.
Revista da Associação Médica Brasileira (2019) Vol. 65, Iss. 2, pp. 110-117
Open Access | Times Cited: 39
H19/TET1 axis promotes TGF‐β signaling linked to endothelial‐to‐mesenchymal transition
Tiefeng Cao, Ying Jiang, Da Li, et al.
The FASEB Journal (2020) Vol. 34, Iss. 6, pp. 8625-8640
Open Access | Times Cited: 29
LncRNA H19: A Novel Biomarker in Cardiovascular Disease.
Xiaojun Li, Yugui Zhang, Zhaoran Ding, et al.
PubMed (2024) Vol. 40, Iss. 2, pp. 172-181
Closed Access | Times Cited: 3
<p>Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer</p>
Xiu Shi, Juan Wang, Shouqian Dai, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12881-12891
Open Access | Times Cited: 25
The function of LncRNA-H19 in cardiac hypertrophy
Wenhua Su, Qian Huo, Hao Wu, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23
LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases
Shifeng Huang, Xiaofei Peng, Lianggui Jiang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis
Qingyu Meng, Luya Pu, Xizi Luo, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 21
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease
Qi Zheng, Glen Reid, Michael R. Eccles, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
LncRNA: An Important Regulator of Atherosclerosis
Yun Ma, Siqi He, Qiao Xie, et al.
Current Medicinal Chemistry (2023) Vol. 30, Iss. 38, pp. 4340-4354
Closed Access | Times Cited: 7
Roles of long non-coding RNAs in angiogenesis-related diseases: Focusing on non-neoplastic aspects
Daisong Li, Lili Liu, Xiangqin He, et al.
Life Sciences (2023) Vol. 330, pp. 122006-122006
Closed Access | Times Cited: 7
lncRNA expression profiles and associated ceRNA network analyses in epicardial adipose tissue of patients with coronary artery disease
Qianchen Wang, Zhenyu Wang, Qian Xu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
LncRNA H19 Mitigates Oxidized Low-Density Lipoprotein Induced Pyroptosis via Caspase-1 in Raw 264.7 Cells
Shan Liu, Dongsheng Xu, Jiulong Ma, et al.
Inflammation (2021) Vol. 44, Iss. 6, pp. 2407-2418
Closed Access | Times Cited: 17
Targeting noncoding RNAs to treat atherosclerosis
Miron Sopić, Sandra Vladimirov, Jelena Munjas, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 2
LncRNAs as Regulators of Atherosclerotic Plaque Stability
Aleksa Petković, Sanja Erceg, Jelena Munjas, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1832-1832
Open Access | Times Cited: 6
Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
Wen-Chu Ye, Shifeng Huang, Lianjie Hou, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top